Bone grafts and substitutes market size to grow by USD 1,450.51 million from 2022 to 2027: Growing prevalence of orthopedic conditions to boost growth - Technavio

NEW YORK, June 23, 2023 /PRNewswire/ -- The global bone grafts and substitutes market size is estimated to increase by USD 1,450.51 million from 2022 to 2027. The market's growth momentum will progress at a CAGR of 8.71%. The growing prevalence of orthopedic conditions is driving market growth. According to Arthritis Foundation, 130 million people across the world may have degenerative joint diseases or disorders by 2050. To treat such conditions, bone grafts and substitutes are used, especially for fractures and dislocation of the lower extremity, total and partial hip replacements, and spinal fusions. In addition, a bone growth stimulation device delivers low-intensity electrical signals that stimulate the natural healing process. Various companies offer bone growth stimulation devices. For instance, Orthofix Medical Inc. offers Physio-Stim for hip fractures. These factors are expected to fuel the global bone grafts and substitutes market during the forecast period. Discover some insights on market size, historic period (2017-2021), and forecast period (2023-2027) before buying the full report - Request a sample report

Bone grafts and substitutes market – Customer landscape

Our report analyzes the life cycle of the global bone grafts and substitutes market from the innovator's stage to the laggard's stage. The report illustrates the lifecycle of the global bone grafts and substitutes market, focusing on the adoption rates of the major countries such as the US, Canada, China, India, Japan, and Germany. To help companies evaluate and develop growth strategies, the report outlines –

• Key purchase criteria
• Adoption rates
• Adoption lifecycles
• Drivers of price sensitivity 
• To unlock the detailed information on the customer landscape - Request a sample now!

Bone grafts and substitutes market – Vendor analysis
Vendor landscape –

The global bone grafts and substitutes market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer bone grafts and substitutes in the market are AlloSource, Arthrex Inc., Baxter International Inc., Bioventus LLC, Geistlich Pharma AG, Integra Lifesciences Holdings Corp., Johnson and Johnson, Medtronic Plc, MTF Biologics, NovaBone Products LLC, Nuvasive Inc., Orthofix Medical Inc., OST Laboratories, RTI Surgical Inc., SeaSpine Holdings Corp., Smith and Nephew plc, Stryker Corp., TBF TISSUE ENGINEERING, Xtant Medical Inc., and Zimmer Biomet Holdings Inc. and others.

Key vendors are acquiring smaller companies, which is intensifying the competition in the market. They are adopting strategies such as M&A, partnerships, strategic collaborations, and R&D to expand their product portfolio and geographical reach. Moreover, new entrants offering technologically advanced products will further intensify the market competition. Therefore, increasing R&D investments and inorganic growth of vendors are likely to boost the growth of the market during the forecast period.

What's new? -

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/active/niche/trivial - Buy the report!

Vendor offerings -

• Bioventus LLC - The company offers solutions for bone grafts and substitutes, which contain calcium and phosphorus, two of the main mineral constituents of bones.
• Geistlich Pharma AG - The company offers solutions for bone grafts and substitutes, which are synthetic, bioabsorbable calcium phosphate molded forms that can be used to fill osseous damage and support osteosynthesis.
• Integra Lifesciences Holdings Corp. - The company offers solutions for bone grafts and substitutes, which are produced in a 3D printing process and available in a variety of versions.
• Nuvasive Inc. - The company offers solutions for bone grafts and substitutes, which consist of beta-tricalcium phosphate (Beta-TCP), where the micro- and macro-porous structure allows it to be resorbed and replaced by bone during the healing process.
• For details on vendors and their offerings – Request a sample report

Bone grafts and substitutes market - Segmentation assessment

Segment overview
Technavio has segmented the market based on product (xenografts, allografts, synthetic bone grafts, and DBM), application (spinal fusion, trauma, craniomaxillofacial, joint reconstruction, and dental bone grafting), and geography (North America, Europe, Asia, and Rest of World (ROW)). 

• The xenografts segment will account for a significant share of market growth during the forecast period. Xenografts refer to transplants between closely related species. They are biological dressings and protect wounds from bacterial and physical trauma. The increasing prevalence of knee and hip injuries, technological advances such as 3D-printed implants, and new product launches by key players are driving the growth of the xenografts segment.

Geography overview
The report provides actionable insights and estimates the contribution of all regions to the growth of the global bone grafts and substitutes market.

• North America is estimated to account for 33% of the growth of the global market during the forecast period. The rising prevalence of orthopedic conditions, product launches, favorable reimbursement for orthopedic implants, and awareness initiatives by governments and non-profit organizations are driving the growth of the market in the region. Vendors are providing performance guarantees to promote the use of bone grafts and substitutes. For instance, in February 2022, Orthofix Medical announced the launch of Opus BA, a synthetic bioactive bone graft solution. The launch of such products is expected to drive market growth during the forecast period.

For insights on global, regional, and country-level parameters with growth opportunities from 2017 to 2027 - Download a sample report

Bone grafts and substitutes market – Market dynamics

Key trends - The growing adoption of minimally invasive surgeries is a key trend in the market. Minimally invasive surgeries provide various advantages, such as lower pain and discomfort, fewer chances of infection and bleeding, shorter hospital stays, decreased chances of scars, and quick recovery. These surgeries are generally preferred for arthroscopy, joint replacement, spine fusion, and other procedures. The presence of specialist orthopedic care centers is expected to increase the adoption of minimally invasive surgeries, which will further increase the use of bone grafts and substitutes. This, in turn, will support market growth during the forecast period.

Major challenges - The high costs associated with implants and procedures may challenge market growth. Orthopedic implants are used for treating conditions related to joints, the spine, and maxillofacial injuries. The cost of bone grafts and substitutes is subject to their applications and features. For instance, the cost of synthetic bone substitutes is high. This can increase the cost burden on end-users and patients. For instance, the average cost of inpatient bone grafting procedures ranges from USD 25,000 to USD 30,000. In addition, the average cost of a CT scan ranges between USD 750 and USD 1,300 per procedure. Such factors are expected to impede the growth of the market during the forecast period.

Drivers, trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this bone grafts and substitutes market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the bone grafts and substitutes market between 2023 and 2027
• Precise estimation of the size of the bone grafts and substitutes market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the bone grafts and substitutes market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of bone grafts and substitutes market vendors

Gain instant access to 17,000+ market research reports. 

Technavio's SUBSCRIPTION platform

Related Reports:

The bone biopsy market is estimated to grow at a CAGR of 7.74% between 2022 and 2027. The size of the market is forecasted to increase by USD 76.77 million. This report extensively covers market segmentation by type (needle biopsy and open biopsy), end-user (hospitals and diagnostic centers), and geography (North America, Europe, Asia, and Rest Of World (ROW)).

The bone cement market is estimated to decline at a CAGR of 5.31% between 2022 and 2027. The size of the market is forecasted to increase by USD 449.08 million. This report extensively covers market segmentation by product (antibiotic-loaded bone cement and non-antibiotic-loaded bone cement), end-user (hospitals, clinics, and ambulatory surgery centers), and geography (North America, Europe, Asia, and Rest of World).

Table of contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global bone grafts and substitutes market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on Global bone grafts and substitutes market 2017 - 2021 ($ million)

• 4.2 Product Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)

• 4.3 Application Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)

• 6.2 Comparison by Product 
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product

• 6.3 Xenografts - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Xenografts - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Xenografts - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Xenografts - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Xenografts - Year-over-year growth 2022-2027 (%)

• 6.4 Allografts - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Allografts - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Allografts - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Allografts - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Allografts - Year-over-year growth 2022-2027 (%)

• 6.5 Synthetic bone grafts - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Synthetic bone grafts - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Synthetic bone grafts - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Synthetic bone grafts - Year-over-year growth 2022-2027 (%)

• 6.6 DBM - Market size and forecast 2022-2027 
• Exhibit 46: Chart on DBM - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on DBM - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on DBM - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on DBM - Year-over-year growth 2022-2027 (%)

• 6.7 Market opportunity by Product 
• Exhibit 50: Market opportunity by Product ($ million)
• Exhibit 51: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 52: Chart on Application - Market share 2022-2027 (%)
• Exhibit 53: Data Table on Application - Market share 2022-2027 (%)

• 7.2 Comparison by Application 
• Exhibit 54: Chart on Comparison by Application
• Exhibit 55: Data Table on Comparison by Application

• 7.3 Spinal fusion - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Spinal fusion - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Spinal fusion - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Spinal fusion - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Spinal fusion - Year-over-year growth 2022-2027 (%)

• 7.4 Trauma - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Trauma - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Trauma - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Trauma - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Trauma - Year-over-year growth 2022-2027 (%)

• 7.5 Craniomaxillofacial - Market size and forecast 2022-2027 
• Exhibit 64: Chart on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Craniomaxillofacial - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Craniomaxillofacial - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Craniomaxillofacial - Year-over-year growth 2022-2027 (%)

• 7.6 Joint reconstruction - Market size and forecast 2022-2027 
• Exhibit 68: Chart on Joint reconstruction - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Data Table on Joint reconstruction - Market size and forecast 2022-2027 ($ million)
• Exhibit 70: Chart on Joint reconstruction - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Joint reconstruction - Year-over-year growth 2022-2027 (%)

• 7.7 Dental bone grafting - Market size and forecast 2022-2027 
• Exhibit 72: Chart on Dental bone grafting - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Data Table on Dental bone grafting - Market size and forecast 2022-2027 ($ million)
• Exhibit 74: Chart on Dental bone grafting - Year-over-year growth 2022-2027 (%)
• Exhibit 75: Data Table on Dental bone grafting - Year-over-year growth 2022-2027 (%)

• 7.8 Market opportunity by Application 
• Exhibit 76: Market opportunity by Application ($ million)
• Exhibit 77: Data Table on Market opportunity by Application ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 79: Chart on Market share by geography 2022-2027 (%)
• Exhibit 80: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 81: Chart on Geographic comparison
• Exhibit 82: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 83: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 87: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 91: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 95: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 99: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Germany - Market size and forecast 2022-2027 
• Exhibit 103: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.9 UK - Market size and forecast 2022-2027 
• Exhibit 107: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on UK - Year-over-year growth 2022-2027 (%)

• 9.10 China - Market size and forecast 2022-2027 
• Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.11 Japan - Market size and forecast 2022-2027 
• Exhibit 115: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 116: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 117: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 118: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 119: Market opportunity by geography ($ million)
• Exhibit 120: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 121: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 122: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 123: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 124: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 125: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 126: Matrix on vendor position and classification

• 12.3 AlloSource
• Exhibit 127: AlloSource - Overview
• Exhibit 128: AlloSource - Product / Service
• Exhibit 129: AlloSource - Key offerings

• 12.4 Arthrex Inc.
• Exhibit 130: Arthrex Inc. - Overview
• Exhibit 131: Arthrex Inc. - Product / Service
• Exhibit 132: Arthrex Inc. - Key offerings

• 12.5 Baxter International Inc. 
• Exhibit 133: Baxter International Inc. - Overview
• Exhibit 134: Baxter International Inc. - Business segments
• Exhibit 135: Baxter International Inc. - Key news
• Exhibit 136: Baxter International Inc. - Key offerings
• Exhibit 137: Baxter International Inc. - Segment focus

• 12.6 Bioventus LLC
• Exhibit 138: Bioventus LLC - Overview
• Exhibit 139: Bioventus LLC - Business segments
• Exhibit 140: Bioventus LLC - Key news
• Exhibit 141: Bioventus LLC - Key offerings
• Exhibit 142: Bioventus LLC - Segment focus

• 12.7 Geistlich Pharma AG
• Exhibit 143: Geistlich Pharma AG - Overview
• Exhibit 144: Geistlich Pharma AG - Product / Service
• Exhibit 145: Geistlich Pharma AG - Key offerings

• 12.8 Integra Lifesciences Holdings Corp. 
• Exhibit 146: Integra Lifesciences Holdings Corp. - Overview
• Exhibit 147: Integra Lifesciences Holdings Corp. - Business segments
• Exhibit 148: Integra Lifesciences Holdings Corp. - Key news
• Exhibit 149: Integra Lifesciences Holdings Corp. - Key offerings
• Exhibit 150: Integra Lifesciences Holdings Corp. - Segment focus

• 12.9 Johnson and Johnson
• Exhibit 151: Johnson and Johnson - Overview
• Exhibit 152: Johnson and Johnson - Business segments
• Exhibit 153: Johnson and Johnson - Key news
• Exhibit 154: Johnson and Johnson - Key offerings
• Exhibit 155: Johnson and Johnson - Segment focus

• 12.10 Medtronic Plc
• Exhibit 156: Medtronic Plc - Overview
• Exhibit 157: Medtronic Plc - Business segments
• Exhibit 158: Medtronic Plc - Key news
• Exhibit 159: Medtronic Plc - Key offerings
• Exhibit 160: Medtronic Plc - Segment focus

• 12.11 MTF Biologics
• Exhibit 161: MTF Biologics - Overview
• Exhibit 162: MTF Biologics - Product / Service
• Exhibit 163: MTF Biologics - Key offerings

• 12.12 NovaBone Products LLC 
• Exhibit 164: NovaBone Products LLC - Overview
• Exhibit 165: NovaBone Products LLC - Product / Service
• Exhibit 166: NovaBone Products LLC - Key offerings

• 12.13 Nuvasive Inc.
• Exhibit 167: Nuvasive Inc. - Overview
• Exhibit 168: Nuvasive Inc. - Business segments
• Exhibit 169: Nuvasive Inc. - Key news
• Exhibit 170: Nuvasive Inc. - Key offerings
• Exhibit 171: Nuvasive Inc. - Segment focus

• 12.14 Orthofix Medical Inc. 
• Exhibit 172: Orthofix Medical Inc. - Overview
• Exhibit 173: Orthofix Medical Inc. - Business segments
• Exhibit 174: Orthofix Medical Inc. - Key news
• Exhibit 175: Orthofix Medical Inc. - Key offerings
• Exhibit 176: Orthofix Medical Inc. - Segment focus

• 12.15 OST Laboratories
• Exhibit 177: OST Laboratories - Overview
• Exhibit 178: OST Laboratories - Product / Service
• Exhibit 179: OST Laboratories - Key offerings

• 12.16 Smith and Nephew plc
• Exhibit 180: Smith and Nephew plc - Overview
• Exhibit 181: Smith and Nephew plc - Business segments
• Exhibit 182: Smith and Nephew plc - Key news
• Exhibit 183: Smith and Nephew plc - Key offerings
• Exhibit 184: Smith and Nephew plc - Segment focus

• 12.17 Stryker Corp.
• Exhibit 185: Stryker Corp. - Overview
• Exhibit 186: Stryker Corp. - Business segments
• Exhibit 187: Stryker Corp. - Key news
• Exhibit 188: Stryker Corp. - Key offerings
• Exhibit 189: Stryker Corp. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 190: Inclusions checklist
• Exhibit 191: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 192: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 193: Research methodology
• Exhibit 194: Validation techniques employed for market sizing
• Exhibit 195: Information sources

• 13.5 List of abbreviations 
• Exhibit 196: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED